Suppressor of cytokine signaling 3 (SOCS3) is not an independent biomarker of colorectal adenoma risk
<p>Abstract</p> <p>Background</p> <p>Inflammation and its associated pathologies are increasingly suggested as risk factors for colorectal cancer (CRC) development. Previous research from our group has shown that increased levels of circulating, pro-inflammatory cytokin...
Main Authors: | Sandler Robert S, Galanko Joseph A, Lund P Kay, Hamilton Kathryn E, Keku Temitope O |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-05-01
|
Series: | BMC Research Notes |
Online Access: | http://www.biomedcentral.com/1756-0500/3/144 |
Similar Items
-
Local IGFBP-3 mRNA expression, apoptosis and risk of colorectal adenomas
by: Omofoye Oluwaseun, et al.
Published: (2008-05-01) -
Elevated C-peptide and insulin predict increased risk of colorectal adenomas in normal mucosa
by: Vidal Adriana C, et al.
Published: (2012-09-01) -
Fusobacterium is associated with colorectal adenomas.
by: Amber N McCoy, et al.
Published: (2013-01-01) -
Role of suppressors of cytokine signaling (SOCS) 3 in bone inflammatory responses
by: Anqi eGao, et al.
Published: (2014-01-01) -
Regulation of insulin and leptin signaling by muscle suppressor of cytokine signaling 3 (SOCS3).
by: Zhenggang Yang, et al.
Published: (2012-01-01)